THE ADHD ORIGINAL. REFINED. Trademark

Trademark Overview

On Wednesday, October 17, 2001, a trademark application was filed for THE ADHD ORIGINAL. REFINED. with the United States Patent and Trademark Office. The USPTO has given the THE ADHD ORIGINAL. REFINED. trademark a serial number of 78088802. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 16, 2011. This trademark is owned by Novartis AG. The THE ADHD ORIGINAL. REFINED. trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of central nervous system diseases and disorders

General Information

Serial Number78088802
Word MarkTHE ADHD ORIGINAL. REFINED.
Filing DateWednesday, October 17, 2001
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 16, 2011
Registration Number2949489
Registration DateTuesday, May 10, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 19, 2002

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of central nervous system diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 16, 2011
Primary Code005
First Use Anywhere DateThursday, August 1, 2002
First Use In Commerce DateThursday, August 1, 2002

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel CH-4056
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel CH-4056
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Friday, December 16, 2011CANCELLED SEC. 8 (6-YR)
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 10, 2005REGISTERED-PRINCIPAL REGISTER
Wednesday, February 2, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, February 2, 2005ASSIGNED TO LIE
Thursday, January 20, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 18, 2005AMENDMENT FROM APPLICANT ENTERED
Wednesday, December 29, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 29, 2004PAPER RECEIVED
Tuesday, January 4, 2005AMENDMENT FROM APPLICANT ENTERED
Monday, December 6, 2004UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Sunday, December 19, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 6, 2004PAPER RECEIVED
Friday, August 20, 2004NON-FINAL ACTION MAILED
Thursday, July 15, 2004ASSIGNED TO EXAMINER
Thursday, June 10, 2004STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 10, 2004USE AMENDMENT FILED
Thursday, June 24, 2004CASE FILE IN TICRS
Thursday, June 10, 2004TEAS STATEMENT OF USE RECEIVED
Thursday, June 10, 2004TEAS EXTENSION RECEIVED
Wednesday, December 3, 2003EXTENSION 3 GRANTED
Saturday, November 22, 2003EXTENSION 3 FILED
Saturday, November 22, 2003TEAS EXTENSION RECEIVED
Wednesday, July 9, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 6, 2003EXTENSION 2 GRANTED
Wednesday, May 21, 2003EXTENSION 2 FILED
Tuesday, May 20, 2003TEAS EXTENSION RECEIVED
Tuesday, December 3, 2002EXTENSION 1 GRANTED
Tuesday, December 3, 2002EXTENSION 1 FILED
Tuesday, December 3, 2002TEAS EXTENSION RECEIVED
Tuesday, June 11, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 19, 2002PUBLISHED FOR OPPOSITION
Wednesday, February 27, 2002NOTICE OF PUBLICATION
Friday, January 11, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 10, 2002ASSIGNED TO EXAMINER

Related Keywords

refined original adhd system diseases disorders nervous central preparations treatment pharmaceutical